A detailed history of Greenleaf Trust transactions in Haleon PLC stock. As of the latest transaction made, Greenleaf Trust holds 17,225 shares of HLN stock, worth $161,742. This represents 0.0% of its overall portfolio holdings.

Number of Shares
17,225
Previous 15,892 8.39%
Holding current value
$161,742
Previous $168,000 2.38%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 24, 2025

BUY
$9.23 - $10.71 $12,303 - $14,276
1,333 Added 8.39%
17,225 $164,000
Q3 2024

Oct 22, 2024

BUY
$8.32 - $10.7 $832 - $1,070
100 Added 0.63%
15,892 $168,000
Q2 2024

Jul 22, 2024

BUY
$8.01 - $8.64 $126,493 - $136,442
15,792 New
15,792 $130,000

Others Institutions Holding HLN

About Haleon plc


  • Ticker HLN
  • Exchange
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 4,617,290,240
  • Market Cap $43.4B
  • Description
  • Haleon plc engages in the research and development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides therapeutic oral health, pain relief, respiratory health, digestive health, and other products, as well as vitamins, mineral...
More about HLN
Track This Portfolio

Track Greenleaf Trust Portfolio

Follow Greenleaf Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Greenleaf Trust, based on Form 13F filings with the SEC.

News

Stay updated on Greenleaf Trust with notifications on news.